JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2004; 43:1954-1958, doi:10.1016/j.jacc.2004.01.045
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoye, A.
Right arrow Articles by Serruys, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoye, A.
Right arrow Articles by Serruys, P. W.

Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions

Angela Hoye, MB, ChB*, Kengo Tanabe, MD*, Pedro A. Lemos, MD*, Jiro Aoki, MD*, Francesco Saia, MD*, Chourmouzios Arampatzis, MD*, Muzaffer Degertekin, MD*, Sjoerd H. Hofma, MD*, Georgios Sianos, MD, PhD*, Eugene McFadden, MB, ChB, FACC*, Willem J. van der Giessen, MD, PhD*, Pieter C. Smits, MD, PhD*, Pim J. de Feyter, MD, PhD, FACC*, Ron T. van Domburg, PhD* and Patrick W. Serruys, MD, PhD, FACC*,*

* Department of Interventional Cardiology, Erasmus MC, Rotterdam, the Netherlands



View larger version (17K):

[in a new window]
  		Figure 1 Kaplan-Meier curves for survival-free of death, acute myocardial infarction, or target vessel revascularization.

 


View larger version (37K):

[in a new window]
  		Figure 2 The percentage binary restenosis rate (>50% diameter stenosis) and reocclusion rate of Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital registry (RESEARCH) compared with published data from the patients treated with stent implantation in the randomized trials Stenting in Chronic Coronary Occlusion (SICCO) (5), Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche (GISSOC) (6), Stents in Total Occlusion for Restenosis Prevention (STOP) (7), and the Total Occlusion Study of Canada (TOSCA) (8). DS = diameter stenosis. *p < 0.05 compared with the results of RESEARCH; {dagger}p < 0.01 compared with the results of RESEARCH.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.